Minicircle, a gene therapy startup, aims to extend human life and improve biological function with a simple 30-second injection of follistatin—a hormone enhancing muscle mass and recovery. While its treatments are not yet approved in the U.S., patients can seek therapy abroad. The potential benefits include reducing inflammation, increasing lifespan, and improving overall quality of life. The founder, Mac Davis, emphasizes a shift from symptom management to proactive health improvements through gene therapy, which might transform future medical practices.
"Gene therapy, at its core, offers the possibility to address issues before they become problems, focusing on enhancing function rather than simply treating dysfunction."
"We want to extend the length and quality of human life."
Collection
[
|
...
]